Trials / Unknown
UnknownNCT02397525
An Open-Label Study to Evaluate Retreatment With LIPO-202
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Neothetics, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the safety of three 8-week courses of treatment with LIPO-202 in non-obese patients who have central abdominal bulging. Efficacy measurements will also be collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LIPO-202 |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-06-01
- First posted
- 2015-03-25
- Last updated
- 2015-08-13
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02397525. Inclusion in this directory is not an endorsement.